ZNF703 overexpression is associated with poor prognosis in luminal BC, colorectal cancers, head and neck squamous carcinomas, cholangiocarcinomas, and ovarian cancers [34,38,41,42,43,44,45,47,50]. Here, ZNF703 is linked to breast cancer.